Emibetuzumab
Product Specifications
CAS Number
1365287-97-3
Target
C-Met/HGFR
Related Pathways
Tyrosine Kinase/Adaptors
Purity
0.988
Bioactivity
Emibetuzumab is a potent humanized bivalent MET antibody (IgG4 type) . Emibetuzumab has antitumor activity, inhibition of HGF-dependent and independent MET pathway activation and tumor growth, and can be used to study advanced castration-resistant prostate cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
